Clinical Trial

Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2024 (before its estimated March 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective:To evaluate the efficacy of different administration protocols of human dental pulp mesenchymal stem cells for the treatment of chronic periodontitis patients. The secondary objective:To evaluate the safety of different administration protocols of human dental pulp mesenchymal stem cells for the treatment of chronic periodontitis patients. The exploratory objective:To investigate the effects of human dental pulp mesenchymal stem cells on biomarkers in gingival crevicular fluid in chronic periodontitis patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-20.
Status change: Not Yet Recruiting → Recruiting 2024-05-26
Trial Details
NCT Number NCT05924373
Lead Sponsor Peking University Third Hospital
Collaborators: Capital Medical University
Conditions Periodontitis
Enrollment 204 participants
Start Date 2023-11-27
Primary Completion 2025-03-07 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-05-29